ArticleDiagnostics (Basel, Switzerland)2022

Clinical Performance Evaluation of the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Assay.

Georgios Meletis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.